Featured News
Charles River and Valo Health Announce Strategic Partnership
Transforming the drug discovery process with integrated artificial intelligence (AI)
Charles River and Valo Health are blending their expertise in science and AI-powered human-centric data and computation to reshape the entire preclinical drug discovery process.
Recognizing the challenges of preclinical drug discovery, this multiyear partnership will leverage our drug discovery and development capabilities with Valo’s Opal Computational Platform to offer a new, transformative, AI-enabled drug discovery and development platform.